Personalis Management
Management criteria checks 1/4
Personalis' CEO is Chris Hall, appointed in Dec 2022, has a tenure of 1.42 years. total yearly compensation is $1.73M, comprised of 30.9% salary and 69.1% bonuses, including company stock and options. directly owns 0.07% of the company’s shares, worth €51.89K. The average tenure of the management team and the board of directors is 2.8 years and 2 years respectively.
Key information
Chris Hall
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 30.9% |
| CEO tenure | 1.4yrs |
| CEO ownership | 0.07% |
| Management average tenure | 2.8yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$534k | -US$108m |
| Sep 30 2023 | n/a | n/a | -US$113m |
| Jun 30 2023 | n/a | n/a | -US$110m |
| Mar 31 2023 | n/a | n/a | -US$114m |
| Dec 31 2022 | US$2m | US$83k | -US$113m |
Compensation vs Market: Chris's total compensation ($USD1.73M) is above average for companies of similar size in the German market ($USD400.67K).
Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.
CEO
Chris Hall (54 yo)
1.4yrs
Tenure
US$1,726,790
Compensation
Mr. Christopher M. Hall, also known as Chris, served as Senior Vice President and Head of Diagnostics Business at Personalis, Inc. since October 2022 until December 31, 2022 and serves as its President sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.4yrs | US$1.73m | 0.070% $ 51.9k | |
| CFO & COO | 5.2yrs | US$1.67m | 0.29% $ 212.5k | |
| Senior VP | 4.1yrs | US$674.28k | 0.083% $ 61.3k | |
| Executive VP of R&D and Chief Medical Officer | 2.8yrs | US$1.28m | 0.18% $ 131.7k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Vice President of Worldwide Sales | 11.1yrs | no data | no data | |
| Senior Vice President of Genomic Laboratory Operations | 2.7yrs | no data | no data | |
| Senior Vice President of Business Development | 1.3yrs | no data | no data | |
| Senior Vice President of Regulatory | less than a year | no data | no data |
2.8yrs
Average Tenure
52yo
Average Age
Experienced Management: 04X's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | US$1.73m | 0.070% $ 51.9k | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Co-Founder and Member of Clinical & Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | US$154.00k | no data | |
| Independent Chair of the Board | 4.7yrs | US$173.05k | 0.026% $ 19.6k | |
| Independent Director | 5yrs | US$121.38k | 0.026% $ 19.6k | |
| Independent Director | 3.2yrs | US$108.88k | 0.051% $ 37.9k | |
| Advisor to the Board | 1.4yrs | US$5.62m | 0% $ 0 | |
| Independent Director | 1.8yrs | US$103.88k | 0.020% $ 15.0k | |
| Independent Director | 2.2yrs | US$116.38k | 0.034% $ 25.5k |
2.0yrs
Average Tenure
66yo
Average Age
Experienced Board: 04X's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.